Seeing Is Believing
VINC is currently covered by 4 analysts with an average price target of $9.35. This is a potential upside of $9.07 (3239.29%) from yesterday's end of day stock price of $0.28.
Vincerx Pharma's activity chart (see below) currently has 5 price targets and 18 ratings on display. The stock rating distribution of VINC is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 30.95% with an average time for these price targets to be met of 347.14 days.
Highest price target for VINC is $6, Lowest price target is $1, average price target is $9.35.
Most recent stock forecast was given by LI WATSEK from CANTOR FITZGERALD on 01-Apr-2024. First documented stock forecast 13-Aug-2021.
Currently out of the existing stock ratings of VINC, 10 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$8
7 months 20 days ago
(01-Apr-2024)
1/2 (50%)
$6.06 (312.37%)
642
Buy
$3
$-1.78 (-37.24%)
$4
2 years 5 days ago
(16-Nov-2022)
2/3 (66.67%)
$2.2 (275.00%)
546
Buy
$5
$0.22 (4.60%)
$6
2 years 3 months 9 days ago
(12-Aug-2022)
2/3 (66.67%)
$3.42 (216.46%)
604
Buy
$6
$1.22 (25.52%)
$12
2 years 5 months 14 days ago
(07-Jun-2022)
1/3 (33.33%)
$4.03 (204.57%)
638
Buy
$30
2 years 7 months 17 days ago
(04-Apr-2022)
0/2 (0%)
$13.71 (84.35%)
What is VINC (Vincerx Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on VINC (Vincerx Pharma) with a proven track record?
Which analyst has the current lower performing score on VINC (Vincerx Pharma) with a proven track record?
Which analyst has the most public recommendations on VINC (Vincerx Pharma)?
Which analyst is the currently most bullish on VINC (Vincerx Pharma)?
Which analyst is the currently most reserved on VINC (Vincerx Pharma)?